How an Activist Group Helped Torpedo MDMA Therapy
After more than three decades of planning and a $250 million investment, Lykos Therapeutics’ application for the first psychedelic drug to reach federal regulators was expected to be a shoo-in.…
Online Therapy Boom Has Mainly Benefited Privileged Groups, Studies Find
The number of Americans receiving psychotherapy increased by 30 percent during the pandemic, as virtual sessions replaced in-person appointments — but new research dampens the hope that technology will make…